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Abstract
Human iPS cells have been generated using a diverse range of tissues from a variety of donors using different
reprogramming vectors. However, these cell lines are heterogeneous, which presents a limitation for their use in disease
modeling and personalized medicine. To explore the basis of this heterogeneity we generated 25 iPS cell lines under
normalised conditions from the same set of somatic tissues across a number of donors. RNA-seq data sets from each cell line
were compared to identify the majority contributors to transcriptional heterogeneity. We found that genetic differences
between individual donors were the major cause of transcriptional variation between lines. In contrast, residual signatures
from the somatic cell of origin, so called epigenetic memory, contributed relatively little to transcriptional variation. Thus,
underlying genetic background variation is responsible for most heterogeneity between human iPS cell lines. We conclude
that epigenetic effects in hIPSCs are minimal, and that hIPSCs are a stable, robust and powerful platform for large-scale
studies of the function of genetic differences between individuals. Our data also suggest that future studies using hIPSCs as
a model system should focus most effort on collection of large numbers of donors, rather than generating large numbers of
lines from the same donor.
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Introduction
Induced pluripotent stem cells (iPSCs) are the subject of
tremendous interest as model systems for studying human disease
and development [1,2]. However, cellular reprogramming to
iPSCs is an inefficient process in which stochastic events during
clonal selection may fix a variety of alternative epigenetic and
transcriptional states[3]. Some reports have described significant
variation between iPS cells and ES cells, while others have
suggested that iPS cells retain a memory of the somatic tissue from
which they were derived that may negatively affect their
differentiation efficiency into certain cell lineages [4–10]. Howev-
er, comparisons between human iPS cells and ES cells are
confounded with differences in genetic background because the
lines are derived from different donors. Likewise, because
collection of multiple primary tissues from the same individual is
frequently impractical, studies of cellular memory in hiPS cells
have often confounded iPS source tissue type and donor genetic
background. This is important because many cellular phenotypes,
including transcription and methylation, are substantially impact-
ed by genetic differences between individuals [11–13].
In this study we set out to understand the basis of this variation
by establishing a set of iPS cells from a panel of tissues isolated in
parallel from several different donors. RNA-seq data sets from
these lines, the corresponding adult somatic cells and human ES
cells have been systematically compared. This has enabled us to
investigate patterns of expression, splicing and imprinting between
these iPS cells, their adult cell progenitors and compare these with
hES cells. Using a statistical model we estimated the relative
contributions of genetic background and tissue of origin to
transcriptional variability between human iPS cell lines.
Results
We established primary fibroblast, keratinocyte and endothelial
progenitor cell (EPC) somatic cell lines from three healthy male
organ donors, labeled S2, S5 and S7, and one healthy female
donor (S4). From each primary adult tissue cell line, we derived at
least three independent iPS cell lines for each donor. For the adult
cell cultures we extracted RNA following each of three passages to
give a total of 18 RNA samples from adult donor cells (6 fibroblast,
3 keratinocyte and 9 EPCs). We also extracted RNA from the iPS
cell lines derived from each of these tissues to give a total of 9 RNA
samples from fibroblast-derived iPSCs (F-iPSCs), 6 from kerati-
nocyte-derived iPSCs (K-iPSCs) and 10 EPC-derived iPSCs (E-
iPSCs). Finally, we also extracted 4 RNA samples from two ES cell
lines, H9 and Val9. Throughout our study highly standardized
conditions were used. This included the isolation, derivation and
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culture of primary cell cells as well as use of the same batches of
reprogramming viruses, serum and media. Each of the primary
cell lines were reprogrammed using the four Yamanaka factors to
generate a series of 25 iPS cell lines derived from each of the three
adult tissues (hereafter F-, K- and E-iPS cells). The differentiation
properties of our iPS cell lines were checked by differentiating a
subset to endoderm, mesoderm and neuroectoderm derived cell
types (Figure S1). Polyadenylated mRNA was prepared from each
iPS cell line after 10 passages, the somatic cell lines at passage 3
and from two human ES cell lines which was subjected to high-
depth RNA-seq (Fig. 1a). We checked a subset of lines for Sendai
virus persistence using RT-PCR with virus-specific primers, but
found no evidence for viral presence following passage (Figure S2).
For each sample, we performed 75 bp paired end sequencing on
the Illumina HiSeq2000 platform. In total we generated 7.3 billion
reads, with between 85.3 and 229.8 million reads sequenced in
each sample (Figure S3). We mapped reads to assembly h37 of the
human genome using Bowtie2 [14] and constructed spliced
alignments using Tophat2 [15]. Following read alignment and
QC filtering, between 49% and 89% of reads mapped uniquely to
the human genome (Figure S4).
Initially we examined the global pattern of transcription in the
different cell lines. Previous work has suggested that embryonic
stem cells are more transcriptionally active than differentiated cells
[16]. Within protein coding regions there was a clear bimodal
distribution of gene expression levels in all samples reflecting
abundantly expressed and transcriptionally repressed genes (Figure
S5). Adult cell lines exhibited more completely repressed and very
highly expressed genes compared with hiPS cells and hES.
Relative to differentiated lineages approximately twice as many
genes could be classified as coming from the repressed mode of
the distribution in the adult cell lines compared with hiPS cells
and ES cells (Figure S 5, inset). We also found that more
transcription appeared to be originate from repetitive elements in
pluripotent stem cells (Figure S6), although it is unclear whether
this arises from a slightly more relaxed chromatin structure in stem
cells, or is an artifact resulting from the slight excess of very
highly expressed genes in somatic cells relative to pluripotent stem
cells.
Variance component analysis of transcription levels
Next, we sought to quantify the contribution of multiple
biological and experimental factors to transcriptional variation in
hiPSCs. Hierarchical clustering clearly placed adult somatic cells
and pluripotent cells in two distinct clades (Fig. 1b). However other
sources of variation, such as tissue of origin, were more difficult to
discern. To quantify the relative importance of different sources of
global transcriptional variation more precisely we employed a
variance component analysis. Here, transcriptional variation was
decomposed into five separate components. These components
comprised: (1) a random intercept term (2) a component to capture
variation in transcription between the three adult somatic tissues,
hESCs and hiPSCs (3) a component modeling differences between
F-, K- and E-iPSCs (4) a component capturing transcriptional
variation between different donors or genetic backgrounds and (5)
a component captures differences between the two sequencing
batches in our data set (see Text S1). We quantified the
contribution of each of the five components using intraclass
correlation, which measures the proportion of total transcriptional
variance explained (VE) by different experimental groups holding
other model factors constant. As such, the estimated VEs for
each component are not constrained to sum to 100%. Through-
out, we modeled the effect of sequencing batch to disentangle its
potential influence from the other variance components in the
model.
We found that inter-individual transcriptional variation in hiPS
cells (VE ,38%) is considerably larger than that between
somatic tissue of origin (VE,4%) with an even smaller fraction
of transcriptional variation (,1%) explained by differences
between iPSCs and ESCs (Fig. 1c). Strikingly, when we didn’t
correct for variation between individuals, transcriptional varia-
tion between iPSCs and ESCs and between different iPSC
tissues of origin appeared to be much larger (,1% vs 12.7%,
iPSCs vs ESCs, 4% vs 13.5%, iPSC tissue of origin, with versus
without individual included in the model, respectively) (Fig1c).
This suggests that some previous observations of cellular
memory and transcriptional differences between iPSCs and
ESCS may in fact arise from changing genetic backgrounds
rather than experimental effects. Confounding with donor
genetic background seems particularly plausible for comparisons
between iPSCs and ESCs where controlling for genetic
differences is often impossible [4,17], or in cases where iPSC
tissue of origin is confounded with donor genetic background
[9,18]. We found that fibroblast- and keratinocyte-derived iPS
cells (F- and K-iPSCs) were highly similar at the transcriptional
level with tissue of origin explaining ,1% of the transcriptional
variation in the between them. In fact, the majority of the tissue
of origin effect we observe arises from differences between F/K-
iPS cells and EPC-derived iPS cells (E-iPS cells). Some of this
signal could reflect transcriptional memory. However it is
possible that the reprogramming method could account for this
difference because the EPCs were resistant to Sendai virus
infection and were therefore derived using the retroviral
method. Individual transcriptional variation was slightly greater
in adult somatic cells (VE,42%) than in stem cells. We
speculate that this could potentially be explained by non-genetic
differences between individuals, such as varying methylation
status, which are present in somatic cells but erased during
cellular reprogramming.
We also examined the amount of residual transcriptional
variation that remained unexplained by any of the known factors
using a heteroscedastic model (Text S1). This extension of the
model allowed us to capture differences in residual variance
between different subsets of our data set. In our experiment, the
Author Summary
Human induced pluripotent stem (hiPS) cells are a
potentially powerful model system for studying human
disease and development, and a resource for personalized
medicine. However, it has been reported that hiPS cells
exhibit substantial heterogeneity which could limit their
use as model systems. Clearly, knowledge of the source of
heterogeneity is key for deeper understanding of the use
of human iPS cells for basic and therapeutic applications.
One source of this heterogeneity has been presumed to be
‘‘memory’’ of the adult somatic cell from which the hIPS
cells were derived, but the evidence to support this view is
scant. We have generated a set of human iPS cells from a
set of somatic cell types from different donors. Our study
shows that cell lines from different somatic sources but
from the same donor (i.e. with the same genome) are more
similar than cell lines isolated from the same tissue type
but from different donors. Once genetic changes are
accounted for, all aspects of gene expression, including
mRNA levels, splicing and imprinting are highly similar
between iPS cells derived from different human tissues.
Thus, most of the previously described transcriptional
variation between cell lines is likely to be genetic in origin.
Transcriptional Variation in Human IPSCs
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residual variance captures transcriptional variation between
different cell lines from the same donor, either as growths of
different IPS cell lines derived from the same donor, from different
growths of either the ESCs or as different passages of adult cells
from the same donor. We compared two heteroscedastic models
with a homoscedastic model, which contained a single error term
for the entire data set (Figure 1d, ‘‘All’’). Heteroscedastic model 1
(‘‘model 1’’) contained three terms representing variation between
biological replicates of adult cells, IPS cells and ESCs. The results
of this analysis illustrate that the residual variation between
replicates of IPS cells is lower than that in adult cells and ESCs
(Figure 1d: Heteroscedastic Model 1 ‘‘F/K/E-iPSCs’’ versus
‘‘ESC’’). Heteroscedastic model 2 further divided error into
components for each of the three different adult cell types, for each
of the three IPS cell types and for ESCs. This analysis
demonstrated that variation between biological replicates of IPS
lines derived from different tissues was relatively consistent
(Figure 1d: Heteroscedastic Model 2). Overall, our data suggest
that transcriptional variation between biological replicates of iPS
cells was not substantially, and may be somewhat lower, different
from that between passages of an established hES cell line or of
adult primary cells.
Given that our variance component analysis was based on
FPKM values, we also reanalyzed data excluding highly expressed
genes, as this may impact our results. We found that our
component estimates and correlation heatmap were qualitatively
very similar when the top 1 and 5% of genes were removed from
the data set (Figure S7, S8). We also attempted a similar analysis of
mitochondrial gene expression. We found similar proportions of
reads coming from mitochondrial genes in adult, IPS and ES cells
(Figure S9). However, the very low number of expressed genes (13)
resulted in extremely noisy estimates of the correlation between
sample gene expression profiles (Figure S10) and prohibited
variance components analysis, due to failure of the model to
converge. Our differential expression analysis classified all mito-
chondrial genes as ‘‘invariant expression’’ (data not shown). Our
experiment did not include multiple replicates from the same cell
line, and so we were unable to formally address the issue of variation
between lines from the same donor. Visual inspection of our read
coverage plots did suggest that some cell lines might be more
variable than others. Heatmaps of the differentially expressed genes
illustrate that while most cell lines were quite consistent, one cell line
derived from keratinocytes formed an outgroup (K-iPSC-S2-1) with
other keratinocyte cell lines (Figure S11).
Figure 1. Experimental design and variance components analysis of transcription in iPSCs, somatic progenitors, H9 and Val9
embryonic stem cells. (a) Schematic showing experimental design. (b) Heatmap of Pearson correlation coefficients of log2 FPKMs (fragments per
kilobase of exon per million fragments mapped) across all genes in all samples (N= 47). Complete-linkage clustering on the correlation coefficients
was performed to order samples by similarity. (c) Decomposition of transcriptional variation using a linear mixed model. Each bar shows the
percentage of transcriptional variance explained (%VE) by each of the components, holding all other factors constant (see Text S1 section 1.3 for
details). Bars show the percentage variance explained between iPS and ES cells d222/(d
2
22+s2) (orange); between adult tissues d221/(d221+s2) (purple);
between iPSC somatic tissue of origin d232/(d
2
32+s2) (pink); between individual (iPSCs) d241/(d242+s2) (red); between individual (adult tissues) d241/
(d241+s2) (green) and between sequencing batches d25/(d25+s2)(blue). d2 and s2 parameters are explained in section 1.3 of Text S1. Red text denotes
variance explained by a component in a model that excluded an individual component, black text denotes variance explained in a model including
an individual component. Panels show layered covariance matrices Zj Dj Zj for the variance components j (j = 2…5) of which the correlation heatmap
in Figure 1b consists. The color corresponds to each of variance components in the barchart of Figure 1c and white color corresponds to covariance
of 0. The sample order of the layered matrices is compatible with Figure 1b. (d) Bars show the estimate of residual variance parameters estimated
from a homoscedastic and two heteroscedastic models. ‘‘Homoscedastic model’’ represents a model with a single error term shared over all samples
in the data set, and the estimate of this error term is labeled ‘‘All’’. The heteroscedastic models 1 and 2 are described in the main text and in the
Supplement (Section 1.3.3. ‘‘Heteroscedastic Model’’. Each bar shows the estimate of a residual error parameter as outlined the Supplement section
1.3.3.
doi:10.1371/journal.pgen.1004432.g001
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Cellular memory and aberrant reprogramming are rare in
hIPS cells
Although our variance components analysis suggested relatively
small global effects of tissue of origin, this could mask effects at
individual genes. We next sought to identify those genes whose
expression in hiPS cells more closely resembled their somatic
progenitors or were improperly silenced or activated, relative to
ES cells (Fig. 2a). For each of the three somatic tissues in turn, we
performed a three-way comparison of expression levels in the
somatic tissue, in the hiPS cells derived from that tissue, and in the
hES cells. At each gene we tested for departures from a null
hypothesis of equal expression levels in the somatic cell, the iPS
Figure 2. Effects of cell type and tissues of origin on expression levels in iPSCs. (a) Schematic of hypothesis testing approach to identify
genes with invariant expression (IE) from genes that we defined as correctly reprogrammed (CR), aberrantly reprogrammed (AR), with transcriptional
memory (TM) and showing complex expression. Genes showing complex expression are further classified into partial AR (PAR) and partial TM (PTM)
according to the expression patterns. (b) Percentages of genes assigned to alternative differential expression groups based on a hierarchical model
(see Text S1 1.4.3). (c) Volcano plots of differentially expressed genes. Plots show log10 of minimum P-values among the four alternative hypotheses
against log2 fold change of average expression levels between iPSCs and ESCs. The colours of points indicate the differential expression categories
into which a gene was classified. Dashed lines show twofold enrichment of mean expression levels between iPSCs and ESCs. FDR thresholds were
calculated by permutation. (d) Read coverage depth in three examples of differentially expressed genes; SOX2, was categorised as correctly
reprogrammed in all three tissues (F-iPSCs: p,1610224; K-iPSCs: p,1.2610216;E-iPSCs: p,4.6610225), H19 was categorised as aberrantly
reprogrammed in all three tissues (F-iPSCs: p,1.261026; K-iPSCs: p,2.761024;E-iPSCs: p,1.5610216) and TYW3 gene was categorised as partial
transcriptional memory in E-iPSCs (p,7.161028), invariant expression in F-iPSCs (p.0.1) and correctly reprogrammed in K-iPSCs (p,1.461023).
Coverage depth was truncated at 1000 reads per bp.
doi:10.1371/journal.pgen.1004432.g002
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cells and the ES cells using a negative binomial generalized linear
model similar to that outlined in [19] (Text S1). When the null
hypothesis (‘‘invariant expression’’) was rejected we further
classified genes into one of four possible categories, ‘‘correctly
reprogrammed’’, ‘‘transcriptional memory’’, ‘‘aberrantly repro-
grammed’’ and ‘‘complex’’ by selecting the alternative with the
highest log likelihood ratio.
We used a hierarchical model (Text S1), similar to that in [20],
to estimate the true proportion of transcribed genes in each category
without setting a threshold on statistical significance or effect size.
Our results suggested that transcriptional memory is very uncom-
mon, occurring at 0.06, 0.06 and 0.20% of all expressed genes in F-,
K- and E-iPS cells (Fig 2b). Aberrant or complex expression
patterns were also infrequent, although aberrant expression
appeared slightly more often in E-iPSCs (0.15% of genes) than in
the other two tissues. The fractions falling into the complex category
were similarly low (0.10, 0.02 and 0.74% of genes, respectively). The
remaining genes either showed invariant expression or were
classified as correctly reprogrammed (99.83, 99.92 and 98.92%).
Core pluripotency markers, including Sox2, Nanog and Oct4, were
all classified as correctly reprogrammed (Figure S12). Our analysis
suggested that the fraction of correctly reprogrammed genes is
approximately 30-60% of expressed genes. Although comparison
between different studies and methodologies difficult, this is not
dissimilar to fraction of genes that are differentially expressed in
reprogramming found by other studies [21]).
Next we identified individual loci that were differentially
expressed at a genome-wide false discovery rate (FDR) of 5%
(estimated from permuted data), and that exhibited a 1.5-fold or
greater change in expression level between hiPS cells and hES
cells. Using these criteria we identified a total of 61, 5 and 103
transcribed regions that showed some form of differential
expression in F-, K-, or E-iPS cells respectively (Table 1), the
majority of which exhibited either complete or partial transcrip-
tional memory (‘‘TM’’ or ‘‘PTM’’). Most genes we identified were
very weakly expressed in IPS cells, with mean FPKMs 74–79%
lower than the average (Figure S13). The most enriched gene
ontology (GO) terms in the TM and PTM gene sets were for
mesodermal migration in F-iPS cells (enrichment q-value ,
0.002;), for hemidesmosome development in K-iPS cells (q,0.03)
and for inflammatory and defense response in E-iPS cells (q,
361025) (Figure S14). Aberrantly expressed genes were less
frequent than genes exhibiting transcriptional memory. One
interesting exception to this was the long noncoding RNA, H19,
which was highly expressed in the majority of hiPS cells in our
data set relative to the hES cells (Fig. 2d). Our differential
expression analysis also suggested that aberrant activation occurs
more often than aberrant silencing (21 versus 6 genes at FDR 5%),
and that transcriptional memory more frequently involves
memory of an active rather than a silenced gene (101 versus 19
genes at FDR 5%) (Table 1). However, this may simply reflect
better power to detect differential expression when a gene is highly
expressed rather than silenced. Removal of highly expressed genes
had almost no impact on our differential expression analysis
(Figures S6, S7). Finally, differential expression analysis of
mitochondrial genes classified all 13 genes we found be expressed
in any of our samples as ‘‘invariant expression’’. Overall, our
results suggest that, although transcriptional memory and aberrant
reprogramming do occur occasionally, relatively few genes are
involved, those that are affected are weakly expressed.
RNA splicing patterns in hIPS cells resemble ES cells
Although whole gene expression levels appeared to be relatively
stable across different tissues of origin, cellular memory could also
manifest at the level of RNA splicing. Using the statistical
framework we developed for gene expression levels, we next tested
whether isoform abundance ratios showed evidence of memory of
their cell type of origin (Text S1). In this analysis, we tested the null
hypothesis that the ratio of the top two most abundant isoforms
was equal in adult tissues, iPS cells and ES cells. We computed
abundances using two popular approaches, Cufflinks2 and MISO
[22,23], and analysed the subset of genes where the ranking of
isoform abundances agreed between the two methods (Figure
S15). We found no significant memory of adult cell splice patterns
or aberrant alternative splicing in IPS at an FDR of 5% estimated
from permuted data (Figure S16). This suggests that transcrip-
tional memory of cellular splice patterns or aberrant splicing
induced during reprogramming is a relatively weak effect, smaller
than that observed at the level of whole gene expression, and
potentially masked by larger technical and genetic effects.
Imprinting is conserved between iPS cells and their
somatic cell of origin
Previous studies have suggested that imprinted gene expression
patterns may be unstable in hES cells and hIPS cells [24]. We
genotyped the four individuals from whom our hIPS cell lines were
derived using an Illumina Omni2.5 genotyping chip. Genotypes
were phased, and SNP genotypes were imputed using Beagle [25].
Using the phased haplotypes, we computed estimates of allele-
specific expression for the paternal and maternal chromosomes of
each individual. We began by investigating whether patterns of
imprinting observed in the adult somatic tissue remained
conserved in the iPS cells that were derived from them in a set
of 210 putatively imprinted genes obtained from the http://www.
geneimprint.com/database. We found that many genes were
expressed at a low level or lacked sufficient coverage of
heterozygous SNPs, which were subsequently excluded. The
remaining genes (26, 23 and 23 in donor S2, S4 and S7,
respectively) exhibited allelic expression patterns in adult cells that
were conserved in their derived iPS cell lines (Pearson r2 = 0.46;
p,6.3610210), Fig 3. Many genes did not demonstrate the
characteristic mono-allelic expression of imprinted genes in either
adult or pluripotent cells (Fig 3). In a small number of cases, such
as the paternally expressed zinc finger gene, ZDBF2, we observed
a loss of imprinting and reversion to bi-allelic expression in many
IPS lines. We note that, in the cases where we observe loss or
alteration of imprinting, the genes involved are relatively weakly
expressed in either the adult or the IPS cell, making ascertainment
of imprinting status more difficult.
Detecting known genetic effects on gene expression in
hIPSCs
Finally we returned to the effects of the genetic background in
our hiPS cells. Extensive maps of genetic variants whose genotype
correlates with gene expression (expression quantitative trait loci,
eQTLs) have been generated in adult human tissues and cell lines
[26]. We investigated whether similar effects could be observed in
our iPS cells. Since the number of individuals in our data set was
small, a standard eQTL mapping experiment was not possible.
Instead, we tested whether genetic associations ascertained in
lymphoblastoid cell lines (LCLs), a model system for eQTL
detection in humans, were also detectable in iPS cells.
We reanalyzed an existing LCL RNA-seq dataset derived from
the same source population (162 GBR+CEU individuals) as our
hiPS cells (Figure S17) and identified 4,350 eQTLs at an FDR of
5% [27]. Variance component analysis revealed a greater amount
of variation between individuals in genes that were ascertained to
Transcriptional Variation in Human IPSCs
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have an eQTL in LCLs, than in genes where the null of no eQTL
could not be rejected (Fig 4a). A substantial fraction (17%) of this
variation could be explained by the lead eQTL SNPs (eSNPs). We
tested whether the direction of the genetic effect at the LCL eQTL
genes replicated in iPS cells by grouping the four individuals in our
data set according to their eSNP genotype. We found that the
expression level of genes with an eQTL ascertained in LCLs follows
the expected direction in hiPS cells (Fig. 4b). Likewise, for
individuals in our dataset that are heterozygous at the eSNP we
see a corresponding, highly significant allelic imbalance also in the
expected direction (Fig. 4c). The correlation between genotype and
expression level at ascertained eQTLs in hiPS cells was highly
significant (Pearson r = 0.44, p,9.8610268), as was the allelic
imbalance at heterozygous ascertained eSNPs (Student t, p,
1.361028). Although our data set is small, we do find convincing
examples where a correlation between genotype and gene
expression replicated a known eQTL identified in LCLs such as
the exonic eSNP, rs1059307, located within the noncoding RNA
gene SNHG5. At this gene, we also observe clear allelic imbalance
in iPS cells derived from S5 and S7 individuals, who are
heterozygous for this eSNP (Fig. 4e), which is in the same direction
as the eQTL effect in LCLs (Fig. 4f). These genetic effects on gene
expression in iPS cells were detectable across multiple independent
iPS cells from the same genetic background, despite the variety of
different tissues sources and reprogramming methods.
Discussion
We have shown that epigenetic memory of the adult progenitor
cell is a rare phenomenon in hIPS cells, and that cellular
heterogeneity between different hIPS lines is more likely to be
driven by changing genetic background. Our study has important
implications for future attempts to use iPSCs as cellular model
systems for drug discovery and other applications. Encouragingly,
our results suggest that genetic effects are readily detected in
hIPSCs and that cell phenotypes are highly reproducible within
individuals. Equally important, however, is the fact that the noise
introduced by genetic background could potentially obscure small
genetic signals of interest in small samples. A clear implication of
this result is that, in iPSC-based studies of genetic disease, most
effort should be expended on collection of samples from different
donors rather than generation of large numbers of lines from the
same individual. Collection of multiple individuals, perhaps with a
shared genotype at a single locus of interest, will allow the effects of
genetic background to be averaged over and separated from that
of the putatively causal locus.
Our study also highlights how the effects of genetic background
cannot be ignored when considering cellular variability between
pluripotent stem cell lines. Previous studies have attributed cellular
variability in IPS to a range of sources, including epigenetic memory
[5–10,17], inherent differences between IPSCs and ESCs [4,28],
artifacts of reprogramming [7] or lab environment [29]. Perhaps
surprisingly, the effects of genetic background have been less well
appreciated, althoughmore recent work has highlighted its potential
importance in differentiation [30]. It seems likely that at least some
of variability previously reported to exist in IPS cells could in fact
have arisen from genetic differences. This is particularly true of
comparisons of IPS with ES that are typically derived from different
individuals. It is also notable that studies including larger numbers
of donors tend to find fewer transcriptional differences between IPS
and ES [29,31–33]. Studies that have not controlled for genetic
background when investigating epigenetic memory, such as by
confounding tissue of origin and donor, may also have mistakenly
attributed genetically driven differences in transcription to epige-
netic memory. Our study explicitly incorporates multiple tissues
from the same donors, allowing us to correct for the effects of
changing genetic background. This is likely to explain why we do
not find extensive apparent epigenetic memory. We note, however,
that other studies that have also explicitly controlled for genetic
background still report some variation in transcription, methylation
and differentiation efficiencies that appear to arise from cell type of
origin effects [5,8,10]. A possible explanation for the discrepancy
between the results of these studies and our own is that we have also
taken our samples from cells at between 10 and 13 passages and
epigenetic memory effects may be transient and disappear following
multiple passages [8].
An important caveat for our study is that influential cellular
differences may simply not manifest as transcriptional variation
but reside at, for example, the epigenetic level as changes in
methylation status or histone tail modifications. Such differences
may harbor a ‘‘hidden’’ functional role that only becomes
apparent upon differentiation into a specific cell lineage. Our
study suggests that epigenetic differences are likely to be more
plausible candidates as drivers of variation in IPS cell differenti-
ation ability. However, our results also illustrate that current iPS
cell technology is robust enough to enable detection of genetic
effects on important cellular phenotypes such as mRNA levels.
Although further technological hurdles remain, an exciting area
for future work will be detection of regulatory variation that
influences transcription during cell lineage specification and
differentiation, employing iPS cells as a model system.
Materials and Methods
Samples
All primary tissue samples and blood for this project were
obtained from adult cadaveric organ transplant donors referred to
Table 1. Numbers of significantly (FDR%) differentially expressed genes in each differential expression category.
AR PAR TM PTM Total
F-iPSC 9 1 8 43 61
K-iPSC 0 0 1 4 5
E-iPSC 4 15 5 79 103
Activation 6 15 9 92 122
Silencing 6 0 2 17 25
Total 12 15 11 109 147
AR: Aberrant reprogramming; PAR: Partial AR; TM: Transcriptional memory; PTM; Partial TM.
doi:10.1371/journal.pgen.1004432.t001
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Figure 3. Imprinting effects on transcription in adult and iPS cells. (a) Allelic imbalance between adult cells and iPS cells for each donor (S2,
S4 and S7). (b) The mosaic plots for each cell line show the allelic imbalance at multiple heterozygous SNP loci throughout the transcribed region.
Each row corresponds to a sample, and each box corresponds to a single heterozygous SNP. Box width is proportional to the total nucleotide count
at the heterozygous SNP, with the box bisected in proportion to the paternal and maternal nucleotide counts (blue and orange) based on the
phasing haplotype information. Examples show consistent loss of imprinting in iPSCs (ZDBF2) and in adult cells (IFG2).
doi:10.1371/journal.pgen.1004432.g003
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the Eastern Organ Donation Services Team (part of NHS Blood
and Transplant). Ethics approval was obtained from the local
Research Ethics Committee (REC No. 09/H306/73).
Derivation of fibroblasts and keratinocytes from skin
samples
For each subject included in this study, a sample of skin was
excised from the midline surgical incision. The skin was transported
to the lab and washed in iodine and ethanol and was cut into
approximately 1 mm3 pieces. These were dispersed evenly on a
90 mm plate and incubated with fibroblast media (Knockout
DMEMand 10% FBS). Outgrowths of fibroblasts and keratinocytes
from the skin explants were usually apparent at around 14 days. The
cells were separately harvested using 5 min treatment with Versene
(15040-066, Invitrogen), which detached the fibroblasts leaving the
keratinocytes on the plate. The fibroblasts were cultured on non-
coated plates using fibroblast media and keratinocytes were cultured
on plates coated with matrix (R011K, Invitrogen) and using EpiLife
media plus Defined Growth Supplement (M-EPI-500-CA and S-
012-5, Invitrogen).
Derivation of Endothelial Progenitor Cells (EPCs)
Endothelial Progenitor Cells were derived from 100 mL of
peripheral blood as previously described [11]. Briefly, the
mononuclear cells of the blood sample were separated using
Ficoll. The cells were cultured on collagen-coated plates using
EPC media (EGM-2MV supplemented with growth factors plus
20% Hyclone serum; CC-3202, Lonza and HYC-001-331G;
Thermo Scientific Hyclone respectively). Colonies of EPCs
appeared at around 10 days.
Generation of EPC-hiPSCs using retroviruses
Four pseudotyped Moloney murine leukemia retroviruses
containing the coding sequences each of human OCT-4, SOX-
2, KLF-4 and C-MYC were obtained from Vectalys (Toulouse,
France). A multiplicity of infection of 10 was used in all retroviral
reprogramming experiments. For each hiPS cell derivation, 16105
EPCs were transfected with the 4 viruses in the presence of 10 ug/
mL of polybrene (TR-1003-G, Millipore). After 24 hrs the viruses
were washed off with PBS and the cells were re-fed with EPC
media that remained for the next 4 days. On day 5 after
transduction, the cells were re-plated using trypsin onto a 10 cm
dish of fresh MEF feeders. After 2 days the media was changed
from primary cell-specific to hiPSC media (KSR + FGF-2). The
media was changed every 2 days until colonies emerged after
which the media was changed daily. Colonies were picked once
they had reached sufficient size, typically from day 25 following
transduction. The colony was split into quarters and the segments
gently lifted off the plate and transferred to one well of a 12 well
plate of fresh MEF feeders containing hiPS cell media (KSR +
FGF2) supplemented with ROCK inhibitor (Y-27632, Sigma).
Generation of F-hiPS cells and K-hiPS cells using Sendai
virus
Four Sendai viruses containing the coding sequences of each of
human OCT-4, SOX-2, KLF-4 and C-MYC were obtained from
Figure 4. Genetic effects on transcription in iPSCs. (a) Variance component of known eQTL genes showing primary eQTL SNPs being able to
explain 17% of FPKM variation on average. Top and bottom 3,000 eQTL genes and SNPs were determined by means of P-values using gEUVADIS
RNA-seq data [27]. (b) Box- plot of log2 FPKM aggregated across 462 eQTL genes (FDR 5%) stratified into high (+/+), medium (+/2) and low (2/2)
genotypes at the minimum p-value eQTL SNPs ascertained from [2] (FDR 5%). Pearson correlation r = 0.44, p,9.8610268. (c) Boxplot of allelic
imbalance at high-expression (+) and low-expression (2) haplotypes across all eQTL genes ascertained from [2]. The red line is at 0.5 indicating the
expected fraction under the null. Student t p,1.361028. (d) Mean RNA-Seq coverage depth in iPSCs, averaged across all iPSC lines from each
individual, at a putative example eQTL for the noncoding RNA SNHG5 gene. Individuals are grouped by their genotype at the putatively causal
variant rs1059307. Individual genotypes are shown with the number of RNA-seq samples in parentheses. (e) Average coverage depth of fragments
coming from the high-expression haplotype (allele T) and low- expression haplotype (allele G) at rs1059307. (f) eQTL association of SNHG5 gene at
rs1059307 in lymphoblastoid cell lines from [2] showing distributions of log2 FPKM against SNP genotypes at rs1059307. The red line shows the best-
fit linear regression line.
doi:10.1371/journal.pgen.1004432.g004
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DNAVec (Ibaraki, Japan). The protocol for reprogramming was
identical to that of retroviruses with the exceptions that 56105
primary cells (fibroblasts or keratinocytes) were used at MOI 3 and
polybrene was not used.
hiPS cell culture
hiPS cells were grown on irradiated MEF feeders, using human
embryonic stem cell media (termed KSR + FGF-2): Advanced
DMEM (12634-010, Invitrogen) was supplemented a follows: 10%
Knockout Serum Replacement (10828028, Invitrogen), 2 mM L-
glutamine (25030024, Invitrogen, 0.1 mM b-mercaptoethanol
(M6250, Sigma-Aldrich) and 4 ng/mL of recombinant human
basic Fibroblast Growth Factor-2 (233-FB-025, R&D systems,
Minneapolis, MO, USA). Media was changed daily and the cells
were passaged every 5–10 days depending on the confluence of the
plates. To passage hiPS cells, the plates were washed in PBS and
colonies detached using collagenase and dispase (Collagenase IV
1 mg/mL, Invitrogen 17104-019; Dispase 1 mg/mL, Invitrogen
17105-041). The colonies were washed in media and mechanically
broken up before being re-plated onto fresh MEF feeders.
RNA extraction
Total RNA was extracted using the RNeasy Mini Kit protocol
(Qiagen, Hilden, Germany). RNA-seq libraries were constructed
according the manufacturers guidelines, with minor modifications,
using the Illumina mRNA-seq and TruSeq mRNA sample
preparation kits (Illumina, Inc., San Diego, CA). Briefly, mRNA
was enriched from total RNA using oligo dT beads before
fragmentation via zinc and heat hydrolysis. mRNA was subject to
first and second strand cDNA synthesis before end repairing and
A-tailing. Double-stranded cDNA was then adapter-ligated before
size-selecting fragments with inserts ranging from 200–300 bp
using a LabChipR XT (Perkin Elmer, Waltham, MA). Size-
selected material was then PCR-amplified using KAPA HiFi
polymerase (Kapa Biosystems, Boston, MA) before sequencing on
an Illumina HiSeq2000 (Illumina, Inc., San Diego, CA).
Computational and statistical analysis
We mapped reads to assembly h37 of the human genome using
Bowtie2 [14] and constructed spliced alignments using Tophat2
[34] with default settings. We also used known gene annotation
information given by Ensembl release 69 as a guide for the
alignment. Following read mapping, we selected fragments (read-
pairs) where at least one of mate-pairs had a quality score of .10,
aligned with no gaps, with three base mismatches or less. Any read
pairs with an insert size less than 150 bp or greater than 1 Mb, or
on different chromosomes, were excluded from subsequent
analyses. Computational analysis was carried out using a
combination of existing packages, such as DESeq [19] and our
own analysis tools. For the variance components analysis,
transcription level at each gene j was modeled as a linear
combination of five normally distributed random effects (b1–5) and
a single error term:
~yj~Z1b1jzZ2b2jzZ3b3jzZ4b4jzZ5b5jz"j
where ~yj is a vector of log normalized fragments per kilobase per
million reads sequenced (FPKMs) for gene j in each of the 46
samples in our data set, b1 is an intercept term, b2 models variation
in transcription between the three adult somatic tissues, hESCs
and hiPSCs, b3 models differences between F-, K- and E-iPSCs, b4
captures transcriptional variation between different donors, b5
captures differences between the two sequencing batches in our
data set, e is the error term and Z1-Z5 are design matrices. For full
details of computational and statistical analyses, see Text S1.
Data
Our raw sequence data are available from the European
Genotype Archive under study ID EGAS00001000367. A variety
of processed data, including raw read counts, log2 FPKMS and
the results of our differential expression analysis are available from
our lab website (http://www.sanger.ac.uk/research/projects/
genomicsofgeneregulation/) under the ‘‘Data’’ tab.
Supporting Information
Figure S1 Differentiation of iPSCs to endo-, meso- and
neuroectoderm. hIPSCs generated using Sendai Virus can
differentiate into cells expressing markers specific of the three
germ layers. hIPSCs (S5SF5) were differentiated into neurocto-
derm, endoderm and mesoderm using defined culture conditions
as described previously [13]. The resulting cells were analysed for
the expression of specific germ layers markers using immuno-
staining. Blue fluorescence shows DAPI staining. Similar results
were obtained with other hIPSCs lines used for this study. Scale
bar 100 mM.
(JPG)
Figure S2 RT-PCR for Sendai viral genome and transgenes in a
subset of lines. Gels show results of RT-PCR using viral primer
sets as described in the CytoTune-iPS reprogramming kit
(Invitrogen) in line S4SK4 (passage 3). Results are shown are for
Sendai virus genome (SeV: 181 bp amplicon), Sendai-derived
exogenous Oct3/4 (O: 483 bp amplicon), Sox2 (S: 451 bp am-
plicon), Klf4 (K: 410 bp amplicon) and cMyc (M: 532 bp
amplicon).
(PDF)
Figure S3 The number of sequenced reads for each sample.
Polyadenylated RNA was extracted from each cell culture and
multiplexed cDNA libraries were synthesized. For each sample, we
performed 75 bp paired end sequencing on the Illumina
HiSeq2000 platform. In total we generated 7.3 billion reads, with
between 85.3 and 229.8 million reads sequenced in each sample.
(PNG)
Figure S4 The number of reads mapped onto the reference
genome for each sample. We mapped reads to assembly h37 of the
human genome using Bowtie2 and constructed spliced alignments
using Tophat2. Following read alignment and QC filtering,
between 49% and 89% of reads mapped uniquely to the human
genome.
(PNG)
Figure S5 Distribution of FPKMs in adult, IPS and ESCs.
Distribution of log10 (FPKM+1) for all known protein coding
genes from ENSEMBL. Each line shows the distribution for a
single sample, with the heavier line showing the mean for each cell
type. Inset shows the probability that gene is classified as coming
from the low/repressed mode of the FPKM distribution estimated
using a two component Gaussian mixture model to classify genes
into active or repressed. Left panel shows distribution for all genes,
right panel excluding the top 1% expression genes.
(PDF)
Figure S6 Percentage reads mapping to LINE and LTRs
elements Bars show the percentage of total mapped reads that
map to LINE and LTR repetitive elements outside known
transcribed regions as annotated in the UCSC repetitive elements
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track. Blue denotes adult cells, orange denotes IPS cells and green
denotes ESCs.
(PDF)
Figure S7 Variance component analysis and differential expres-
sion (DE) analysis excluding highly expressed genes (upper 1%-
tile). (a) Correlation heatmap without upper 1%-tile highly
expressed genes (b) Result of variance component analysis without
upper 1%-tile highly expressed genes. (c) P-value comparison with
original DE analysis. Each panel shows scatter plot of the DE
minimum P-values without upper 1%ile highly expressed genes
(X-axis) against original minimum DE P-values (Y-axis) for each
tissue. Gray vertical and horizontal lines show 5% FDR.
(PDF)
Figure S8 Variance component analysis and differential expres-
sion (DE) analysis with genes without highly expressed genes
(upper 5%-tile). (a) Correlation heatmap without upper 5%-tile
highly expressed genes (b) Result of variance component analysis
without upper 5%-tile highly expressed genes. (c) P-value
comparison with original DE analysis. Each panel shows scatter
plot of the DE minimum P-values without upper 5%-tile highly
expressed genes (X-axis) against original minimum DE P-values
(Y-axis) for each tissue. Gray vertical and horizontal lines show 5%
FDR.
(PDF)
Figure S9 Percentage of total fragments mapping to 13
mitochondrial protein coding genes. Bars show the percentage of
total reads mapping to known mitochondrial genes in all samples
in our data. Blue denotes adult cells, orange denotes IPS cells and
green denotes ESCs.
(PDF)
Figure S10 Mitochondrial gene expression. Correlation heat-
map of log2 FPKMs for 13 mitochondrial protein coding genes.
Map elements show Spearman correlation coefficients.
(PDF)
Figure S11 Heatmaps of log2 FPKMs for partial transcriptional
memory (PTM) genes deter- mined by the differential expression
analysis. (a) Partial transcriptional memory genes in F- iPSCs, (b)
K-iPSCs and (c) E-iPSCs. We note that, although patterns of
expression across most lines are broadly consistent with one
another, line K-iPSC-S2-1-1 forms an outlier from the other K-
iPSCs
(PDF)
Figure S12 Coverage depth plots of core pluripotency marker
genes. Plots show read coverage of three core pluripotency
markers, SOX2, NANOG and OCT4 from left to right.
(PDF)
Figure S13 Mean expression levels of differentially expressed
genes. Plots show the densities of log10(FPKM) in all genes (black
lines) and in genes that were detected as differentially expressed
(DE; either transcriptional memory, or aberrant reprogramming;
red lines) in our analysis.
(PNG)
Figure S14 Coverage depth plots of genes driving Gene
Ontology enrichments in F- and K-iPS cells. Plots show coverage
depth for four genes, KRT5, KRT14, MESP1 and MESP2, that
were annotated with the most significant Gene Ontology term
enrichments (‘‘hemidesmosome assembly’’ and ‘‘mesoderm mi-
gration involved in gastrulation’’) in K-iPS cells and F-iPS
cells, respectively. Coverage depth was truncated at 500 reads
per bp.
(PDF)
Figure S15 Scatterplot of transcript FPKMs between MISO and
Cufflinks. Plotted is the distribution of FPKMs of all known
annotated transcripts estimated by Cufflinks (X-axis) against
MISO (Y-axis). Overall, the FPKM estimation is consistent so
that many transcripts are seen on the diagonal line. However,
there are also a certain amount of transcripts only enriched in one
of the two methods.
(JPG)
Figure S16 Volcano plots of differential isoform expression.
Plots show log10 of minimum P-values among the four alternative
hypotheses against the maximum log2 fold-change of average
transcript expression levels between iPSCs and ESCs. The colours
of the points indicate the differential expression categories into
which a gene was classified. Dashed lines show twofold enrichment
of mean expression levels between iPSCs and ESCs. The FDR
threshold was calculated by the permutation scheme as in the
differential expression analysis.
(PNG)
Figure S17 Result of population stratification for our samples
(S2/S4/S5/S9) with 1000 Genomes Project data. Principal
component analysis was performed using Eigenstrat [35] with
genome-wide SNP genotypes of European populations obtained
from 1000 Genomes Project. All four samples are clustered with
GBR and CEU populations.
(PNG)
Figure S18 GC content influences inference of expression levels
from RNA-seq. Plotted is the log2 relative enrichment, Fil, against
the mean GC content of bin l for all samples. The red line shows
the fitted spline function, Fil (see Text S1 for details).
(JPG)
Figure S19 Relationship between precision and expression level.
Plotted is the distribution of log tj against average of log2
normalised FPKMs y˜j across all samples (j = 1,…, L).
(PNG)
Text S1 Supplementary methods.
(PDF)
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